Effectdossier · gearchiveerd kwartaal
CRSP
CRISPR Therapeutics AG · Healthcare · Biotechnology
13Gevolgde houders
0Δ houders
27.95MGehouden aandelen
$1.36BGerapporteerde waarde
+1Nieuwe posities
−1Uitstappen
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +4.1% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 115 | +5 | 51.84M | $2.83B | +10 | −4 |
| Q1 2026 | 112 | -2 | 52.07M | $2.48B | +5 | −8 |
| Q4 2025 | 114 | 0 | 52.74M | $2.77B | +1 | — |
| Q3 2025 | 15 | 0 | 31.49M | $2.04B | +1 | −2 |
| Q2 2025 | 13 | 0 | 27.95M | $1.36B | +1 | −1 |
| Q1 2025 | 10 | +2 | 16.56M | $563.38M | +2 | — |
| Q4 2024 | 8 | -2 | 14.13M | $556.07M | — | −2 |
| Q3 2024 | 9 | -1 | 10.14M | $476.58M | — | −1 |
| Q2 2024 | 10 | — | 10.63M | $574.07M | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 10.18M | +0.2% | $495.28M | 3.6% | ▲ Add | 5 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (passief) | 3.27M | +35.6% | $159.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passief) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passief) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passief) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passief) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (passief) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | The Vanguard Group ✦ (passief) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Geode Capital Management ✦ (passief) | 2.07M | +98.1% | $100.79M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Geode Capital Management ✦ (passief) | 2.07M | +98.1% | $100.79M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Fidelity (FMR) ✦ | 1.93M | — | $93.83M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 1.93M | — | $93.83M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Fidelity (FMR) ✦ | 1.93M | — | $93.83M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Two Sigma Investments ✦ | 1.55M | +30.0% | $75.20M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 30 | Norges Bank ✦ (passief) | 406.49K | -10.9% | $19.77M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 31 | Millennium Management ✦ | 70.09K | -88.0% | $3.41M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | T. Rowe Price ✦ | 66.37K | +142.5% | $3.23M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 21.61K | -14.6% | $1.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 21.61K | -14.6% | $1.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 21.61K | -14.6% | $1.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 21.61K | -14.6% | $1.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 37 | Citadel Advisors ✦ | 18.88K | -92.7% | $918,226 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | Gotham Asset Management ✦ | 5.10K | Nieuw | $248,113 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Gotham Asset Management | $248,113 | 0.0% |
Verlaten
| Marshall Wace | $13.38M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 488 houders, 76.60M aandelen, $3.47B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Aug 14
SC 13G/A — ORBIS INVESTMENT MANAGEMENT LTD
Jul 27
SC 13G/A — BlackRock, Inc.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API